SRSF2 and myelodysplastic syndrome: Even in hematopoietic tumor diseases such as myelodysplastic syndromes and acute myeloid leukemia, an association with SRSF2 mutations has been observed, e.g., in correlation with malignant transformation, reduced overall survival, and increased therapy resistance [36].